Advertisement
Advertisement
U.S. markets close in 1 hour 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Rockwell Medical, Inc. (RMTI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0600+0.1200 (+6.19%)
As of 02:42PM EDT. Market open.
Advertisement

Rockwell Medical, Inc.

30142 South Wixom road
Suite 501
Wixom, MI 48393
United States
248 960 9009
https://www.rockwellmed.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees300

Key Executives

NameTitlePayExercisedYear Born
Mr. Russell L. Skibsted M.B.A.Exec. VP, CFO & Chief Bus. Officer598.92kN/A1959
Dr. Mark Strobeck Ph.D.Pres, CEO & DirectorN/AN/A1971
Mr. Michael DeYoungVP of OperationsN/AN/AN/A
Mr. Paul E. McGarryVP, Corp. Controller & Principal Accounting OfficerN/AN/A1968
Ms. Megan C. TimminsSr. VP, Gen. Counsel & Corp. Sec.N/AN/A1973
Mr. James A. McCarthySr. VP of Bus. & Corp. Devel.N/AN/AN/A
Mr. Timothy T. CholeSr. VP of Sales & MarketingN/AN/AN/A
Dr. Marc L. HoffmanChief Medical OfficerN/AN/A1961
Mr. David J. KullSec.N/AN/A1968
Mr. Jason FinkelsteinInvestor Relations RepresentativeN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Corporate Governance

Rockwell Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement